Case study
Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma
February 20, 2023Business Services
PARIS, FRANCE, STRICTLY EMBARGOED until 11.00pm CET, 13 February 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced three-year minimum, …
Booklet labels or Just-In-Time labelling: A question of standards
September 7, 2017Business Services, Manufacturing and Production Faubel, Labelling, packaging
Pharmaceutical companies are multiplying their efforts to establish just-in-time labeling. For Anthony Morrow, Business Development Manager Northern Europe at Faubel, …
High demands: Requirements on the labelling of pharmaceutical products are growing continuously
September 7, 2017Business Services, Manufacturing and Production Faubel, Labelling
There are numerous criteria to be met by label manufacturers. In this context, topics such as patient compliance and smart …
Navigating the challenges of health technology assessment
May 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI, Global Pricing Innovations
In the face of restricted budgets, payers worldwide are increasingly using Health Technology Assessments (HTAs) as a way of managing …
Quotient Clinical receives MHRA Supplementary Accreditation
February 26, 2010Research and Development Quotient
This is one of the highest levels of accreditation in Europe and confirms that Quotient Clinical is qualified to perform …
Latest content
